Literature DB >> 22864942

Locally ablative non-surgical management of colo-rectal liver metastasis.

Amit Bahl1, Rakesh Kapoor, Pramod Kumar Singh, Tapesh Bhattacharya, Oinam S Arun, Tomar Parsee, Suresh C Sharma.   

Abstract

BACKGROUND: Liver is one of the commonest sites of metastasis in colorectal cancer patients. Solitary liver metastasis or oligometastasis are traditionally treated by surgical resection or chemotherapy. DISCUSSION: There may be a subgroup of these patients who are not suitable for surgery or chemotherapy due to various co-morbid factors. These patients can be treated by novel minimally invasive or noninvasive ablative techniques like interstitial brachytherapy, extracranial stereotactic radiotherapy, and radiofrequency ablation.

Entities:  

Mesh:

Year:  2013        PMID: 22864942     DOI: 10.1007/s12029-012-9427-9

Source DB:  PubMed          Journal:  J Gastrointest Cancer


  21 in total

Review 1.  Percutaneous tumor ablation with radiofrequency.

Authors:  Bradford J Wood; Jeffrey R Ramkaransingh; Tito Fojo; McClellan M Walther; Stephen K Libutti
Journal:  Cancer       Date:  2002-01-15       Impact factor: 6.860

2.  A dosimetric model of duodenal toxicity after stereotactic body radiotherapy for pancreatic cancer.

Authors:  James D Murphy; Claudia Christman-Skieller; Jeff Kim; Sonja Dieterich; Daniel T Chang; Albert C Koong
Journal:  Int J Radiat Oncol Biol Phys       Date:  2010-04-14       Impact factor: 7.038

Review 3.  Resection of hepatic metastases from colorectal cancer. Biologic perspective.

Authors:  G Steele; T S Ravikumar
Journal:  Ann Surg       Date:  1989-08       Impact factor: 12.969

4.  Cancer statistics, 2008.

Authors:  Ahmedin Jemal; Rebecca Siegel; Elizabeth Ward; Yongping Hao; Jiaquan Xu; Taylor Murray; Michael J Thun
Journal:  CA Cancer J Clin       Date:  2008-02-20       Impact factor: 508.702

5.  Radiobiological restrictions and tolerance doses of repeated single-fraction hdr-irradiation of intersecting small liver volumes for recurrent hepatic metastases.

Authors:  Ricarda Rühl; Lutz Lüdemann; Anna Czarnecka; Florian Streitparth; Max Seidensticker; Konrad Mohnike; Maciej Pech; Peter Wust; Jens Ricke
Journal:  Radiat Oncol       Date:  2010-05-27       Impact factor: 3.481

Review 6.  Minimally invasive surgery for small breast cancer.

Authors:  Masakuni Noguchi
Journal:  J Surg Oncol       Date:  2003-10       Impact factor: 3.454

7.  Cetuximab monotherapy and cetuximab plus irinotecan in irinotecan-refractory metastatic colorectal cancer.

Authors:  David Cunningham; Yves Humblet; Salvatore Siena; David Khayat; Harry Bleiberg; Armando Santoro; Danny Bets; Matthias Mueser; Andreas Harstrick; Chris Verslype; Ian Chau; Eric Van Cutsem
Journal:  N Engl J Med       Date:  2004-07-22       Impact factor: 91.245

8.  Bevacizumab in combination with oxaliplatin-based chemotherapy as first-line therapy in metastatic colorectal cancer: a randomized phase III study.

Authors:  Leonard B Saltz; Stephen Clarke; Eduardo Díaz-Rubio; Werner Scheithauer; Arie Figer; Ralph Wong; Sheryl Koski; Mikhail Lichinitser; Tsai-Shen Yang; Fernando Rivera; Felix Couture; Florin Sirzén; Jim Cassidy
Journal:  J Clin Oncol       Date:  2008-04-20       Impact factor: 44.544

9.  Stereotactic high dose fraction radiation therapy of extracranial tumors using an accelerator. Clinical experience of the first thirty-one patients.

Authors:  H Blomgren; I Lax; I Näslund; R Svanström
Journal:  Acta Oncol       Date:  1995       Impact factor: 4.089

10.  Percutaneous radiofrequency coagulation of osteoid osteoma compared with operative treatment.

Authors:  D I Rosenthal; F J Hornicek; M W Wolfe; L C Jennings; M C Gebhardt; H J Mankin
Journal:  J Bone Joint Surg Am       Date:  1998-06       Impact factor: 5.284

View more
  1 in total

1.  A single reference measurement can predict liver tumor motion during respiration.

Authors:  Jakub Cvek; Lukas Knybel; Lukas Molenda; Bretislav Otahal; Tomas Jonszta; Daniel Czerny; David Feltl
Journal:  Rep Pract Oncol Radiother       Date:  2015-12-29
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.